Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 315
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2001ROBO1Protein and RNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05 (for protein); p < 0.001 (for mRNA)Tissue28977866
2002EZH2RNAsHumanUpregulated (1.5 fold) Diagnostic HCC v/s Normal p < 0.05Tissue28977866
2003GPC3RNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2004HMMRRNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2005PLVAPRNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2006PTTG1RNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2007TOP2ARNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2008RACGAP1RNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2009ASPMRNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2010CCNB1RNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2011CDKN3RNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2012CENPFRNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2013COL15A1RNAsHumanUpregulated (1.5 fold) DiagnosticHCC v/s Normal p < 0.05Tissue28977866
2017CERS4RNAsHuman Cell linesUpregulated in HCC Potential Diagnostic *HCC v/s Normal p < 0.001Tissue28789368
2021circFUT8circRNAsHumanUpregulated in liver cancer (with fold change 11.44) DiagnosticLiver cancer v/s Normal p < 0.01Tissue28727484
2022circZFRcircRNAsHumanUpregulated in liver cancer (with fold change 13.22) DiagnosticLiver cancer v/s Normal p < 0.001Tissue28727484
2023circIPO11circRNAsHumanUpregulated in liver cancer (with fold change 8.65) DiagnosticLiver cancer v/s Normal p < 0.05Tissue28727484
2032miR-9-3RNAsHumanUpregulated in the liver cancer cell lines (0.33 fold) PrognosticHBV-HCC v/s Normal; Can predict survival of patients p < 0.05Tissue28322348
2033miR-10bRNAsHumanUpregulated in the liver cancer cell lines (0.33 fold) PrognosticHBV-HCC v/s Normal; Can predict survival of patients p < 0.05Tissue28322348
2034miR-31RNAsHumanUpregulated in the liver cancer cell lines (0.33 fold) PrognosticHBV-HCC v/s Normal; Can predict survival of patients p < 0.05Tissue28322348
2035miR-519cRNAsHumanUpregulated in the liver cancer cell lines (0.33 fold) PrognosticHBV-HCC v/s Normal; Can predict survival of patients p < 0.05Tissue28322348
2036miR-522RNAsHumanUpregulated in the liver cancer cell lines (0.33 fold) PrognosticHBV-HCC v/s Normal; Can predict survival of patients p < 0.05Tissue28322348
2037miR-3660RNAsHumanUpregulated in the liver cancer cell lines (0.33 fold) PrognosticHBV-HCC v/s Normal; Can predict survival of patients p < 0.05Tissue28322348
2038miR-4784RNAsHumanUpregulated in the liver cancer cell lines (0.33 fold) PrognosticHBV-HCC v/s Normal; Can predict survival of patients p < 0.05Tissue28322348
2039miR-6883RNAsHumanUpregulated in the liver cancer cell lines (0.33 fold) PrognosticHBV-HCC v/s Normal; Can predict survival of patients p < 0.05Tissue28322348
2040Promoter methylation of HCCS1RNAsHumanNA Diagnostic and PrognosticHCC vs CHB (Chronic hepatitis B); significantly associated with tumor node-metastasis (TNM) stage p < 0.001Serum28189396
2045GABRA3RNAsHumanupregulated in subsets of liver hepatocellular carcinoma (30%) and lung adenocarcinoma (10%) DiagnosticNormal vs cancer p < 0.05Tissue27771326
2046LIN28BRNAsHumanupregulated in subsets of liver hepatocellular carcinoma (30%) and lung adenocarcinoma (10%) DiagnosticNormal vs cancer p < 0.05Tissue27771326
2047MAGEAsRNAsHumanupregulated in subsets of liver hepatocellular carcinoma (30%) and lung adenocarcinoma (10%) DiagnosticNormal vs cancer p < 0.05Tissue27771326
2048RBMYRNAsHumanupregulated in subsets of liver hepatocellular carcinoma (30%) and lung adenocarcinoma (10%) DiagnosticNormal vs cancer p < 0.05Tissue27771326
2049TSPYRNAsHumanupregulated in subsets of liver hepatocellular carcinoma (30%) and lung adenocarcinoma (10%) DiagnosticNormal vs cancer p < 0.05Tissue27771326
2092DLC1RNAsHumanDownregulated in HCC PrognosticCancer v/s Normal; predict survival of patients p < 0.05Tissue26846339
2095IRF1RNAsHumanUpregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticCancer v/s Normal FDR <0.01Cells26811688
2096GBP1RNAsHumanUpregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2097ICAM1RNAsHumanUpregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2098Foxa1RNAsHumanDownregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2099DHCR7RNAsHumanDownregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2100HMGCS2RNAsHumanDownregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2101MSMO1RNAsHumanDownregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) DiagnosticNormal vs HCC FDR <0.01Cells26811688
2102CPERNAsHumanCPE expression level was also significantly correlated with the tumor recurrence for both stage i.e. Stage-I and Stage-II PrognosticRecurrence between stage-I v/s stage-II p < 0.01Tissue26803519
2168CYP1A1RNAsHuman cell linesUpregulated in hepatoma cells Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793
2169CYP1B1RNAsHuman cell linesUpregulated in hepatoma cells Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793
2170GDF15RNAsHuman cell linesUpregulated in hepatoma cell Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793
2171SERPINE1RNAsHuman cell linesUpregulated in hepatoma cells Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793
2172SOS1RNAsHuman cell linesUpregulated in hepatoma cell Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793
2173RASD1RNAsHuman cell linesUpregulated in hepatoma cell Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793
2174MRASRNAsHuman cell linesUpregulated in hepatoma cell Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793
2175NR1H4RNAsHuman cell linesDownregulated in hepatoma cells Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793
2176PALMDRNAsHuman cell linesDownregulated in hepatoma cells Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793
2177TXNIPRNAsHuman cell linesDownregulated in hepatoma cells Potential Predictive *Normal vs hepatoma cells treated with emodin p < 0.0001Cells19895793

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top